IBDEI152 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19019,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19019,1,3,0)
 ;;=3^Personal Hx of Hodgkin Lymphoma
 ;;^UTILITY(U,$J,358.3,19019,1,4,0)
 ;;=4^Z85.71
 ;;^UTILITY(U,$J,358.3,19019,2)
 ;;=^5063435
 ;;^UTILITY(U,$J,358.3,19020,0)
 ;;=Z65.8^^94^917^138
 ;;^UTILITY(U,$J,358.3,19020,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19020,1,3,0)
 ;;=3^Psychosocial Circumstance Related Problems
 ;;^UTILITY(U,$J,358.3,19020,1,4,0)
 ;;=4^Z65.8
 ;;^UTILITY(U,$J,358.3,19020,2)
 ;;=^5063185
 ;;^UTILITY(U,$J,358.3,19021,0)
 ;;=Z86.11^^94^917^115
 ;;^UTILITY(U,$J,358.3,19021,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19021,1,3,0)
 ;;=3^Personal Hx of Tuberculosis
 ;;^UTILITY(U,$J,358.3,19021,1,4,0)
 ;;=4^Z86.11
 ;;^UTILITY(U,$J,358.3,19021,2)
 ;;=^5063461
 ;;^UTILITY(U,$J,358.3,19022,0)
 ;;=Z86.13^^94^917^82
 ;;^UTILITY(U,$J,358.3,19022,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19022,1,3,0)
 ;;=3^Personal Hx of Malaria
 ;;^UTILITY(U,$J,358.3,19022,1,4,0)
 ;;=4^Z86.13
 ;;^UTILITY(U,$J,358.3,19022,2)
 ;;=^5063463
 ;;^UTILITY(U,$J,358.3,19023,0)
 ;;=Z86.73^^94^917^112
 ;;^UTILITY(U,$J,358.3,19023,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19023,1,3,0)
 ;;=3^Personal Hx of TIA & Cereb Infrc w/o Residual Deficits
 ;;^UTILITY(U,$J,358.3,19023,1,4,0)
 ;;=4^Z86.73
 ;;^UTILITY(U,$J,358.3,19023,2)
 ;;=^5063477
 ;;^UTILITY(U,$J,358.3,19024,0)
 ;;=Z86.79^^94^917^75
 ;;^UTILITY(U,$J,358.3,19024,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19024,1,3,0)
 ;;=3^Personal Hx of Circulatory System Diseases
 ;;^UTILITY(U,$J,358.3,19024,1,4,0)
 ;;=4^Z86.79
 ;;^UTILITY(U,$J,358.3,19024,2)
 ;;=^5063479
 ;;^UTILITY(U,$J,358.3,19025,0)
 ;;=Z91.040^^94^917^64
 ;;^UTILITY(U,$J,358.3,19025,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19025,1,3,0)
 ;;=3^Latex Allergy Status
 ;;^UTILITY(U,$J,358.3,19025,1,4,0)
 ;;=4^Z91.040
 ;;^UTILITY(U,$J,358.3,19025,2)
 ;;=^5063607
 ;;^UTILITY(U,$J,358.3,19026,0)
 ;;=Z98.89^^94^917^120
 ;;^UTILITY(U,$J,358.3,19026,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19026,1,3,0)
 ;;=3^Postprocedural States/Hx of Surgery NEC
 ;;^UTILITY(U,$J,358.3,19026,1,4,0)
 ;;=4^Z98.89
 ;;^UTILITY(U,$J,358.3,19026,2)
 ;;=^5063754
 ;;^UTILITY(U,$J,358.3,19027,0)
 ;;=Z92.3^^94^917^79
 ;;^UTILITY(U,$J,358.3,19027,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19027,1,3,0)
 ;;=3^Personal Hx of Irradiation
 ;;^UTILITY(U,$J,358.3,19027,1,4,0)
 ;;=4^Z92.3
 ;;^UTILITY(U,$J,358.3,19027,2)
 ;;=^5063637
 ;;^UTILITY(U,$J,358.3,19028,0)
 ;;=Z91.120^^94^917^60
 ;;^UTILITY(U,$J,358.3,19028,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19028,1,3,0)
 ;;=3^Intentional Underdose of Meds d/t Financial Hardship
 ;;^UTILITY(U,$J,358.3,19028,1,4,0)
 ;;=4^Z91.120
 ;;^UTILITY(U,$J,358.3,19028,2)
 ;;=^5063612
 ;;^UTILITY(U,$J,358.3,19029,0)
 ;;=Z91.11^^94^917^69
 ;;^UTILITY(U,$J,358.3,19029,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19029,1,3,0)
 ;;=3^Noncompliance w/ Dietary Regimen
 ;;^UTILITY(U,$J,358.3,19029,1,4,0)
 ;;=4^Z91.11
 ;;^UTILITY(U,$J,358.3,19029,2)
 ;;=^5063611
 ;;^UTILITY(U,$J,358.3,19030,0)
 ;;=Z87.891^^94^917^103
 ;;^UTILITY(U,$J,358.3,19030,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19030,1,3,0)
 ;;=3^Personal Hx of Nicotine Dependence
 ;;^UTILITY(U,$J,358.3,19030,1,4,0)
 ;;=4^Z87.891
 ;;^UTILITY(U,$J,358.3,19030,2)
 ;;=^5063518
 ;;^UTILITY(U,$J,358.3,19031,0)
 ;;=Z77.090^^94^917^11
 ;;^UTILITY(U,$J,358.3,19031,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19031,1,3,0)
 ;;=3^Asbestos Contact/Exposure
 ;;^UTILITY(U,$J,358.3,19031,1,4,0)
 ;;=4^Z77.090
 ;;^UTILITY(U,$J,358.3,19031,2)
 ;;=^5063312
 ;;^UTILITY(U,$J,358.3,19032,0)
 ;;=Z57.8^^94^917^72
